Unique ID issued by UMIN | UMIN000032295 |
---|---|
Receipt number | R000035666 |
Scientific Title | Selection of Nitrate or Carperitide in acute phase for prevention from Cardiovascular events in patients with acute heart failure. |
Date of disclosure of the study information | 2018/04/18 |
Last modified on | 2018/04/20 21:01:23 |
Selection of Nitrate or Carperitide in acute phase for prevention from Cardiovascular events in patients with acute heart failure.
Selection of Nitrate or Carperitide in acute phase for prevention from Cardiovascular events in patients with acute heart failure.
Selection of Nitrate or Carperitide in acute phase for prevention from Cardiovascular events in patients with acute heart failure.
Selection of Nitrate or Carperitide in acute phase for prevention from Cardiovascular events in patients with acute heart failure.
Japan |
acute heart failure
Cardiology |
Others
NO
This study was aimed to comapre a frequency of composite clinical outcomes between patients treated with carperitide or nitrate: a singlecenter, randomized, open-label, clinical trial.
Efficacy
Frequency of composite cardiovascular event after the initiation of the treatments
1) Changes in NYHA (before, 3hours and 2days after the initiation of the treatments)
2) Echocardiographical changes (LVDd, LVDs, LVEF, E/A, VTI) (before and 14 days after the the initiation of the treatments)
3) Changes in plasma BNP levels (before and 14 days after the the initiation of the treatments)
4) Changes in systolic blood pressure during protocol
5) Changes in estimated GFR during protocol
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
Initial treatments (intravenous administration) is a randomized (1:1) to carperitide and nitrate.
Nitrate
20 | years-old | <= |
Not applicable |
Male and Female
1) over 20 years
2) NYHA functional class: 2-3
3) Systolic blood pressure: greater than or equal to 120mmHg
4) written informed consent
1) Patients with acute myocaridal infarction and unstable angina, which occurs within 3 months
2) Patients with valvular heart disease which requires surgical treatments
3) Patients with persistent fever greater than or equal to 38 degree celcius
4) Patients with cancer
5) Patients who received surgery or significant trauma within 6 months
6) Patients with inflamative disease
7) Patients who requires ventricular assist device
8) Patients who receive dialysis
9) Patients with severe dehydration
10) Patients considered ineligible to participate in this study by physician
140
1st name | |
Middle name | |
Last name | Hiroyuki Takahama |
National Cerebral and Cardiovascular Center
Department of Cardiovascular Medicine
Fujishirodai, 5-7-1, Suita
06-6833-5012
takahama@ncvc.go.jp
1st name | |
Middle name | |
Last name | Hiroyuki Takahama |
National Cerebral and Cardiovascular Center
Department of Cardiovascular Medicine
Fujishirodai, 5-7-1, Suita
06-6833-5012
takahama@ncvc.go.jp
National Cerebral and Cardiovascular Center
National Cerebral and Cardiovascular Center
Other
NO
2018 | Year | 04 | Month | 18 | Day |
Partially published
Completed
2011 | Year | 02 | Month | 08 | Day |
2011 | Year | 02 | Month | 08 | Day |
2014 | Year | 09 | Month | 30 | Day |
2014 | Year | 09 | Month | 30 | Day |
2014 | Year | 09 | Month | 30 | Day |
2014 | Year | 09 | Month | 30 | Day |
2018 | Year | 04 | Month | 17 | Day |
2018 | Year | 04 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035666
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |